Derivative of the Lactobacilus johnsonii strain CNCM I-1225, deficient in D-lactic acid production and with an improved shelf life
AssigneeNestec S.A.
InventorsRaymond-David Pridmore, Francis Foata, Michele Delley, Ivana Jankovic
Life of this patent
Estimating the term…
Abstract
The present invention generally relates to the field of probiotic bacteria. In particular, the present invention relates to natural derivatives of the Lactobacillus johnsonii strain CNCM I-1225 with improved properties. For example, the present invention relates to a natural derivative of the Lactobacillus johnsonii strain CNCM I-1225 that is deficient in D-lactic acid production and exhibits an improved viability during product storage.
Claims8
A method for the treatment or prevention of disorders linked to a weakened immune system comprising administering to an individual in need of same a composition comprising Lactobacillus johnsonii strain CNCM I-4437.
The method as claimed in 2, wherein the composition comprises the Lactobacillus johnsonii strain CNCM I-4437 in an amount of 106-1012 cfu per daily dose.
Dependencies are inferred from the claim text.